Concepedia

Upregulation of Nox4 Promotes Angiotensin II-Induced Epidermal Growth Factor Receptor Activation and Subsequent Cardiac Hypertrophy by Increasing ADAM17 Expression

Xi Chen, Shaorui Chen, Qin Li, Yuhua Wang, Jian Zou, Weiwei Cao, Jiani Luo, Hui Gao, Peiqing Liu

Canadian Journal of Cardiology · 2013 · 34 citations · 18 references

DOI

Concepts

References

18

NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart

Junya Kuroda, Tetsuro Ago, Shouji Matsushima et al. · Proceedings of the National Academy of Sciences · 2010 · 774 citations · Full text

, , +17

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

Masanori Asakura, Masafumi Kitakaze, Seiji Takashima et al. · Nature Medicine · 2002 · 718 citations

, , +7

NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis

Min Zhang, Alison C. Brewer, Katrin Schröder et al. · Proceedings of the National Academy of Sciences · 2010 · 443 citations · Full text

, , +17

Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate

Shigeki Higashiyama, JA Abraham, Michael Klagsbrun · The Journal of Cell Biology · 1993 · 364 citations · Full text

, , +12

NO/redox disequilibrium in the failing heart and cardiovascular system

Joshua M. Hare, Jonathan S. Stamler · Journal of Clinical Investigation · 2005 · 346 citations · Full text

, , +17